Skip to main content
NeuronFeed
Home Investors Eli Lilly and Company

Eli Lilly and Company

Active VC
Portfolio Active
1
Latest Verge Genomics
Deal flow
$98M
1 round
Unicorns
0
≥ $1B valuation
Founded
—
Latest
Dec 2021
Verge Genomics

About Eli Lilly and Company

Venture capital firm tracking 1 AI investment, with focus on AI Healthcare and US startups. Total tracked deal flow: $98M.

Sector focus

🏥 AI Healthcare 1

Geographic focus

US 1

Portfolio

1

Verge Genomics

We use human data and AI to develop better drugs faster

Co-investors

8

Lifeforce Capital

1 shared

Tao Capital Partners

1 shared

ALS Investment Fund

1 shared

Threshold Ventures

1 shared

Vulcan Capital

1 shared

Section 32

1 shared

Merck Global Health Innovation Fund

1 shared

BlackRock

1 shared

Recent rounds

1
Dec 1, 2021 Series B $98M Verge Genomics